CoChat

A proteome-wide atlas of drug mechanism of action

Mitchell, Dylan C., Kuljanin, Miljan, Li, Jiaming, Van Vranken, Jonathan G., Bulloch, Nathan, Schweppe, Devin K., Huttlin, Edward L., Gygi, Steven P. · 2023 · Nature Biotechnology
Cited by 164

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41587-022-01539-0

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Research works printed but not linked: 51

  1. Litichevskiy, L. et al. A library of phosphoproteomic and chromatin signatures for characterizing cellular responses to drug perturbations. Cell Syst. 6, 424–443e7 (2018). · DOI · Paper page
  2. Abelin, J. G. et al. Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes. Mol. Cell Proteomics 15, 1622–1641 (2016). · DOI · Paper page
  3. Chernobrovkin, A. et al. Functional identification of target by expression proteomics (FITExP) reveals protein targets and highlights mechanisms of action of small molecule drugs. Sci. Rep. 5, 11176 (2015). · DOI
  4. Saei, A. A. et al. ProTargetMiner as a proteome signature library of anticancer molecules for functional discovery. Nat. Commun. 10, 5715 (2019). · DOI · Paper page
  5. Ruprecht, B. et al. A mass spectrometry-based proteome map of drug action in lung cancer cell lines. Nat. Chem. Biol. 16, 1111–1119 (2020). · DOI
  6. Bian, Y. et al. Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC-MS/MS. Nat. Commun. 11, 157 (2020). · DOI · Paper page
  7. Li, J. et al. TMTpro reagents: a set of isobaric labeling mass tags enables simultaneous proteome-wide measurements across 16 samples. Nat. Methods 17, 399–404 (2020). · DOI · Paper page
  8. Thompson, A. et al. Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal. Chem. 75, 1895–1904 (2003). · DOI · Paper page
  9. Li, J. et al. Proteome-wide mapping of short-lived proteins in human cells. Mol. Cell 81, 4722–4735 e5 (2021). · DOI · Paper page
  10. Schweppe, D. K. et al. Full-featured, real-time database searching platform enables fast and accurate multiplexed quantitative proteomics. J. Proteome Res. 19, 2026–2034 (2020). · DOI · Paper page
  11. Erickson, B. K. et al. Active instrument engagement combined with a real-time database search for improved performance of sample multiplexing workflows. J. Proteome Res. 18, 1299–1306 (2019). · DOI · Paper page
  12. Misra, S., Ghatak, S. & Toole, B. P. Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2. J. Biol. Chem. 280, 20310–20315 (2005). · DOI · Paper page
  13. Rozengurt, E., Soares, H. P. & Sinnet-Smith, J. Suppression of feedback loops mediated by PI3K/mTOR induces multiple overactivation of compensatory pathways: an unintended consequence leading to drug resistance. Mol. Cancer Ther. 13, 2477–2488 (2014). · DOI · Paper page
  14. Foulds, C. E. Disrupting a negative feedback loop drives endocrine therapy-resistant breast cancer. Proc. Natl Acad. Sci. USA 115, 8236–8238 (2018). · DOI
  15. Iskar, M. et al. Drug-induced regulation of target expression. PLoS Comput. Biol. 6, e1000925 (2010). · DOI · Paper page
  16. Liu, S. et al. Structure-guided design and development of potent and selective dual bromodomain 4 (BRD4)/polo-like kinase 1 (PLK1) inhibitors. J. Med. Chem. 61, 7785–7795 (2018). · DOI
  17. Wrobel, A. et al. Trimethoprim and other nonclassical antifolates an excellent template for searching modifications of dihydrofolate reductase enzyme inhibitors. J. Antibiot. (Tokyo) 73, 5–27 (2020). · DOI · Paper page
  18. Zhang, Y. et al. RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling. Nat. Cell Biol. 13, 623–629 (2011). · DOI · Paper page
  19. Wang, W. et al. Tankyrase inhibitors target YAP by stabilizing angiomotin family proteins. Cell Rep. 13, 524–532 (2015). · DOI · Paper page
  20. Thorsell, A. G. et al. Structural basis for potency and promiscuity in poly(ADP-ribose) polymerase (PARP) and tankyrase inhibitors. J. Med. Chem. 60, 1262–1271 (2017). · DOI · Paper page
  21. Strimmer, K. fdrtool: a versatile R package for estimating local and tail area-based false discovery rates. Bioinformatics 24, 1461–1462 (2008). · DOI · Paper page
  22. Villalonga-Planells, R. et al. Activation of p53 by nutlin-3a induces apoptosis and cellular senescence in human glioblastoma multiforme. PLoS One 6, e18588 (2011). · DOI · Paper page
  23. Hafner, M. et al. Multiomics profiling establishes the polypharmacology of FDA-approved CDK4/6 Inhibitors and the potential for differential clinical activity. Cell Chem. Biol. 26, 1067–1080 e8 (2019). · DOI · Paper page
  24. Picaud, S. et al. RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain. Proc. Natl Acad. Sci. USA 110, 19754–19759 (2013). · DOI · Paper page
  25. Delmore, J. E. et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146, 904–917 (2011). · DOI · Paper page
  26. Boada-Romero, E. et al. TMEM59 defines a novel ATG16L1-binding motif that promotes local activation of LC3. EMBO J. 32, 566–582 (2013). · DOI
  27. Gremke, N. et al. mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability. Nat. Commun. 11, 4684 (2020). · DOI · Paper page
  28. Mauvezin, C. & Neufeld, T. P. Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A/SERCA-dependent autophagosome-lysosome fusion. Autophagy 11, 1437–1438 (2015). · DOI · Paper page
  29. Shen, S. et al. Association and dissociation of autophagy, apoptosis and necrosis by systematic chemical study. Oncogene 30, 4544–4556 (2011). · DOI
  30. Becker, E. & Richardson, D. R. Development of novel aroylhydrazone ligands for iron chelation therapy: 2-pyridylcarboxaldehyde isonicotinoyl hydrazone analogs. J. Lab. Clin. Med. 134, 510–521 (1999). · DOI
  31. Cukierman, D. S. et al. Aroylhydrazones constitute a promising class of ‘metal-protein attenuating compounds’ for the treatment of Alzheimer’s disease: a proof-of-concept based on the study of the interactions between zinc(II) and pyridine-2-carboxaldehyde isonicotinoyl hydrazone. J. Biol. Inorg. Chem. 23, 1227–1241 (2018). · DOI
  32. Lin, A. et al. Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials. Sci. Transl. Med. 11, eaaw8412 (2019). · DOI · Paper page
  33. Li, F. et al. Procaspase-3-activating compound 1 stabilizes hypoxia-inducible factor 1alpha and induces DNA damage by sequestering ferrous iron. Cell Death Dis. 9, 1025 (2018). · DOI
  34. Deeks, E. D. Ibrutinib: a review in chronic lymphocytic leukaemia. Drugs 77, 225–236 (2017). · DOI
  35. Lou, Y. et al. Structure-based drug design of RN486, a potent and selective Bruton’s tyrosine kinase (BTK) inhibitor, for the treatment of rheumatoid arthritis. J. Med. Chem. 58, 512–516 (2015). · DOI · Paper page
  36. Li, J. et al. Selection of heating temperatures improves the sensitivity of the proteome integral solubility alteration assay. J. Proteome Res. 19, 2159–2166 (2020). · DOI · Paper page
  37. An, H. et al. TEX264 is an endoplasmic reticulum-resident ATG8-Interacting protein critical for ER remodeling during nutrient stress. Mol. Cell 74, 891–908e10 (2019). · DOI · Paper page
  38. Chino, H. et al. Intrinsically disordered protein TEX264 mediates ER-phagy. Mol. Cell 74, 909–921e6 (2019). · DOI · Paper page
  39. Tricklebank, M. D. JP-1302: a new tool to shed light on the roles of alpha2C-adrenoceptors in brain. Br. J. Pharmacol. 150, 381–382 (2007). · doi:10.1038/sj.bjp.0707007
  40. Baumli, S. et al. The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation. EMBO J. 27, 1907–1918 (2008). · DOI · Paper page
  41. Chang, H. W. et al. Mechanism of FACT removal from transcribed genes by anticancer drugs curaxins. Sci. Adv. 4, eaav2131 (2018). · DOI
  42. Schenone, M. et al. Target identification and mechanism of action in chemical biology and drug discovery. Nat. Chem. Biol. 9, 232–240 (2013). · DOI · Paper page
  43. Huttlin, E. L. et al. Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. Cell 184, 3022–3040 e28 (2021). · doi:10.1016/j.cell.2021.04.011 · Paper page
  44. Hughes, C. S. et al. Ultrasensitive proteome analysis using paramagnetic bead technology. Mol. Syst. Biol. 10, 757 (2014). · DOI · Paper page
  45. Hughes, C. S. et al. Single-pot, solid-phase-enhanced sample preparation for proteomics experiments. Nat. Protoc. 14, 68–85 (2019). · DOI · Paper page
  46. Liu, X., Gygi, S. P. & Paulo, J. A. A semiautomated paramagnetic bead-based platform for isobaric tag sample preparation. J. Am. Soc. Mass. Spectrom. 32, 1519–1529 (2021). · DOI
  47. Navarrete-Perea, J., Yu, Q., Gygi, S. P. & Paulo, J. A. Streamlined tandem mass tag (SL-TMT) protocol: an efficient strategy for quantitative (phospho)proteome profiling using tandem mass tag-synchronous precursor selection-MS3. J. Proteome Res. 17, 2226–2236 (2018). · DOI · Paper page
  48. Rad, R. et al. Improved monoisotopic mass estimation for deeper proteome coverage. J. Proteome Res. 20, 591–598 (2021). · DOI · Paper page
  49. Savitski, M. M., Wilhelm, M., Hahne, H., Kuster, B. & Bantscheff, M. A scalable approach for protein false discovery rate estimation in large proteomic data sets. Mol. Cell Proteomics 14, 2394–2404 (2015). · DOI · Paper page
  50. Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003). · DOI · Paper page
  51. Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731–740 (2016). · DOI · Paper page

Cited by

See all 164

Metadata

Authors
Mitchell, D. C., Kuljanin, M., Li, J., Van Vranken, J. G., Bulloch, N., Schweppe, D. K., Huttlin, E. L., & Gygi, S. P.
Venue
Nature Biotechnology
Published
2023-01-02
Volume
41
Issue
6
Pages
845-857
ISSN
  • 1087-0156
  • 1546-1696
Cited by
164
References
26
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A proteome-wide atlas of drug mechanism of action. https://app.cochat.ai/papers/10.1038/s41587-022-01539-0
The paper
Mitchell, D. C., Kuljanin, M., Li, J., Van Vranken, J. G., Bulloch, N., Schweppe, D. K., Huttlin, E. L., & Gygi, S. P. (2023). A proteome-wide atlas of drug mechanism of action. Nature Biotechnology. https://doi.org/10.1038/s41587-022-01539-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.